Legal status CA: Schedule II PubChem CID 119058030 Formula C23H23N3O Molar mass 357.5 g/mol | CAS Number 1391484-80-2 ChemSpider 29763729 3D model (Jmol) Interactive image | |
 | ||
MN 18 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen.
Legal status
MN-18 is banned in Sweden. On 15 September 2014 the Turkey government banned the sale of MN-18
References
MN-18 Wikipedia(Text) CC BY-SA